These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6232326)

  • 1. Endogenous interferon in Argentine hemorrhagic fever.
    Levis SC; Saavedra MC; Ceccoli C; Falcoff E; Feuillade MR; Enria DA; Maiztegui JI; Falcoff R
    J Infect Dis; 1984 Mar; 149(3):428-33. PubMed ID: 6232326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation between endogenous interferon and the clinical evolution of patients with Argentine hemorrhagic fever.
    Levis SC; Saavedra MC; Ceccoli C; Feuillade MR; Enria DA; Maiztegui JI; Falcoff R
    J Interferon Res; 1985; 5(3):383-9. PubMed ID: 4056485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating interferon in the guinea pig infected with the XJ, prototype Junin virus strain.
    Dejean CB; Oubiña JR; Carballal G; Teyssié AR
    J Med Virol; 1988 Jan; 24(1):97-9. PubMed ID: 2828536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relation of endogenous interferon and high levels of 2'-5' oligoadenylate synthetase in leukocytes from patients with Argentine hemorrhagic fever.
    Ferbus D; Saavedra MC; Levis S; Maiztegui J; Falcoff R
    J Infect Dis; 1988 May; 157(5):1061-4. PubMed ID: 3361147
    [No Abstract]   [Full Text] [Related]  

  • 5. Activity of a platelet protein kinase that phosphorylates fibrinogen and histone in Argentine hemorrhagic fever.
    Lerer GD; Saavedra MC; Falcoff R; Maiztegui JI; Molinas FC
    Acta Physiol Pharmacol Ther Latinoam; 1991; 41(4):377-86. PubMed ID: 1726921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current status of the treatment of Argentine Hemorrhagic Fever.
    Enría D; Franco SG; Ambrosio A; Vallejos D; Levis S; Maiztegui J
    Med Microbiol Immunol; 1986; 175(2-3):173-6. PubMed ID: 3014290
    [No Abstract]   [Full Text] [Related]  

  • 7. Antiviral treatment of Argentine hemorrhagic fever.
    Enria DA; Maiztegui JI
    Antiviral Res; 1994 Jan; 23(1):23-31. PubMed ID: 8141590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Junin virus isolation from lympho-mononuclear cells of patients with Argentine hemorrhagic fever.
    Ambrosio AM; Enria DA; Maiztegui JI
    Intervirology; 1986; 25(2):97-102. PubMed ID: 3013799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A plasma inhibitor of platelet aggregation in patients with Argentine hemorrhagic fever.
    Cummins D; Molinas FC; Lerer G; Maiztegui JI; Faint R; Machin SJ
    Am J Trop Med Hyg; 1990 May; 42(5):470-5. PubMed ID: 2160197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protection of Junín virus-infected marmosets by passive administration of immune serum: association with late neurologic signs.
    Avila MM; Samoilovich SR; Laguens RP; Merani MS; Weissenbacher MC
    J Med Virol; 1987 Jan; 21(1):67-74. PubMed ID: 3025358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tolerance and antiviral effect of ribavirin in patients with Argentine hemorrhagic fever.
    Enria DA; Briggiler AM; Levis S; Vallejos D; Maiztegui JI; Canonico PG
    Antiviral Res; 1987 Jul; 7(6):353-9. PubMed ID: 2445283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factor VIII: C and factor VIII R: Ag in Argentine hemorrhagic fever.
    Molinas FC; Maiztegui JI
    Thromb Haemost; 1981 Aug; 46(2):525-7. PubMed ID: 6795740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of Argentine hemorrhagic fever.
    Enria DA; Briggiler AM; Sánchez Z
    Antiviral Res; 2008 Apr; 78(1):132-9. PubMed ID: 18054395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Type I interferon underlies severe disease associated with Junín virus infection in mice.
    Hickerson BT; Sefing EJ; Bailey KW; Van Wettere AJ; Penichet ML; Gowen BB
    Elife; 2020 May; 9():. PubMed ID: 32452770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Importance of dose of neutralising antibodies in treatment of Argentine haemorrhagic fever with immune plasma.
    Enria DA; Briggiler AM; Fernandez NJ; Levis SC; Maiztegui JI
    Lancet; 1984 Aug; 2(8397):255-6. PubMed ID: 6146809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prevalence of hepatitis C antibodies in plasma donors for the treatment of Argentine hemorrhagic fever].
    Saavedra MC; Briggiler AM; Enría D; Riera L; Ambrosio AM
    Medicina (B Aires); 1997; 57(3):287-93. PubMed ID: 9640761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of junin virus-infected guinea pigs with immune serum: development of late neurological disease.
    Kenyon RH; Green DE; Eddy GA; Peters CJ
    J Med Virol; 1986 Nov; 20(3):207-18. PubMed ID: 3023540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between hematopoietic growth factors levels and hematological parameters in Argentine hemorrhagic fever.
    Marta RF; Enria D; Molinas FC
    Am J Hematol; 2000 May; 64(1):1-6. PubMed ID: 10815780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of cell fusion in Junin virus-infected cells by sera from Argentine hemorrhagic fever patients.
    Castilla V; Contigiani M; Mersich SE
    J Clin Virol; 2005 Apr; 32(4):286-8. PubMed ID: 15780806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical case definitions for Argentine hemorrhagic fever.
    Harrison LH; Halsey NA; McKee KT; Peters CJ; Barrera Oro JG; Briggiler AM; Feuillade MR; Maiztegui JI
    Clin Infect Dis; 1999 May; 28(5):1091-4. PubMed ID: 10452640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.